Reduces upper end of its normalized EBITDA guidance of $1.01B to 1%, and is increasing the lower end to -2% due to strong Q1 2025 performance. Q2 normalized EBITDA is expected to be 7%-8% lower than Q1 normalized EBITDA of $266M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOBO: